Home/Surflay Nanotec/Dr. Lars Dähne
DL

Dr. Lars Dähne

CEO

Surflay Nanotec

Surflay Nanotec Pipeline

DrugIndicationPhase
WhisperSense DevelopmentProtein Interaction AnalysisProduct Development
Advanced LFA ParticlesDiagnostic Assay ComponentsProduct Development
Targeted Drug Delivery SystemsVarious (Collaborative R&D)Pre-clinical R&D
Encapsulated AgrochemicalsSustainable AgricultureProduct Development